Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis. (Q38770830)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26969258%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

title

Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26969258%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26969258%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Francisco M. Marty

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26969258%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Oliver A Cornely

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26969258%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

David Fredricks

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26969258%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Werner J. Heinz

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26969258%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Nikolay Klimko

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26969258%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Jo-Anne H. Young

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26969258%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Souha Kanj

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26969258%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Luis L Ostrosky-Zeichner

2

object named as

Luis Ostrosky-Zeichner

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26969258%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

17

Peter G Pappas

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26969258%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Jörg Janne Vehreschild

22

object named as

J Janne Vehreschild

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26969258%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Maria J G T Vehreschild

34

object named as

Maria J G T Vehreschild

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26969258%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

author name string

Kathleen M Mullane

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26969258%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

George R Thompson

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26969258%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

George J Alangaden

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26969258%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Janice M Brown

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26969258%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Galina Klyasova

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26969258%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Johan A Maertens

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26969258%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Sameer R Melinkeri

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26969258%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Ilana Oren

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26969258%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Zdeněk Ráčil

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26969258%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Galia Rahav

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26969258%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Rodrigo Santos

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26969258%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Stefan Schwartz

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26969258%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Sutep Jaruratanasirikul

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26969258%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Marc Engelhardt

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26969258%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Achim Kaufhold

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26969258%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Masanori Ito

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26969258%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Misun Lee

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26969258%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Carolyn Sasse

31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26969258%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Rochelle M Maher

32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26969258%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Bernhardt Zeiher

33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26969258%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

VITAL and FungiScope Mucormycosis Investigators

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26969258%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

John R Perfect

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26969258%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Ploenchan Chetchotisakd

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26969258%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

publication date

9 March 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26969258%20AND%20SRC:MED&resulttype=core&format=json

Lancet Infectious Diseases

10 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26969258%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

volume

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26969258%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

page(s)

828-837

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26969258%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26969258%20AND%20SRC:MED&resulttype=core&format=json

Epidemiology and outcome of zygomycosis: a review of 929 reported cases

10 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900071-2

7 January 2021

Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900071-2

7 January 2021

Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900071-2

7 January 2021

Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900071-2

7 January 2021

ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900071-2

7 January 2021

In vitro susceptibilities of 217 clinical isolates of zygomycetes to conventional and new antifungal agents

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900071-2

7 January 2021

In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900071-2

7 January 2021

Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900071-2

7 January 2021

Posaconazole as salvage therapy for zygomycosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900071-2

7 January 2021

Posaconazole is effective as salvage therapy in zygomycosis: a retrospective summary of 91 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900071-2

7 January 2021

Isavuconazole: A New Broad-Spectrum Triazole Antifungal Agent

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900071-2

7 January 2021

Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900071-2

7 January 2021

Forty-one recent cases of invasive zygomycosis from a global clinical registry.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900071-2

7 January 2021

Apophysomyces elegans: epidemiology, amplified fragment length polymorphism typing, and in vitro antifungal susceptibility pattern

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900071-2

7 January 2021

A global analysis of mucormycosis in France: the RetroZygo Study (2005-2007).

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900071-2

7 January 2021

Primary treatment of zygomycosis with liposomal amphotericin B: analysis of 28 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900071-2

7 January 2021

Zygomycosis in solid organ transplant recipients: a prospective, matched case-control study to assess risks for disease and outcome

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900071-2

7 January 2021

Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteria

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900071-2

7 January 2021

Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900071-2

7 January 2021

Mucormycosis-associated fungal infections in patients with haematologic malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900071-2

7 January 2021

Prospective pilot study of high-dose (10 mg/kg/day) liposomal amphotericin B (L-AMB) for the initial treatment of mucormycosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900071-2

7 January 2021

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900071-2

7 January 2021

Comparative pharmacodynamics of posaconazole in neutropenic murine models of invasive pulmonary aspergillosis and mucormycosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900071-2

7 January 2021

Isavuconazole therapy protects immunosuppressed mice from mucormycosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900071-2

7 January 2021

Efficacy of liposomal amphotericin B and posaconazole in intratracheal models of murine mucormycosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900071-2

7 January 2021

Fungus-specific CD4(+) T cells for rapid identification of invasive pulmonary mold infection.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900071-2

7 January 2021

A breath fungal secondary metabolite signature to diagnose invasive aspergillosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900071-2

7 January 2021

Quantitative polymerase chain reaction detection of circulating DNA in serum for early diagnosis of mucormycosis in immunocompromised patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2900071-2

7 January 2021

10.1016/S1473-3099(16)00071-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26969258%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

1 reference